Blue Light Therapy Helps Recovery from Mild TBI
|
By HospiMedica International staff writers Posted on 27 Jan 2020 |

Image: University of Arizona research technician tests a blue light device (Photo courtesy of William Killgore)
A new study suggests that exposing the retinohypothalamic system in the eye to blue light can assist mild traumatic brain injury (mTBI) recovery.
Researchers at the University of Arizona (Tucson, USA) conducted a randomized, double-blind, placebo-controlled trial of 32 adults (18–48 years of age) recovering from a recent mTBI. The researchers compared of cumulative six weeks of daily 30-minute pulses of blue light (469 nm) each morning to an amber (578 nm) placebo light on neurocognitive and neuroimaging outcomes, including gray matter volume (GMV), resting-state functional connectivity, directed connectivity using Granger causality, and white matter integrity using diffusion tensor imaging (DTI).
According to the researchers, blue light suppresses brain production of melatonin. Exposure to blue light in the morning shifts the brain's biological clock so that is produced earlier, aligning it with the natural circadian rhythm. The results showed that relative to placebo, morning blue light led to phase-advanced sleep timing, reduced daytime sleepiness, higher executive functioning, increased GMV of the posterior thalamus, greater thalamo-cortical functional connectivity, and increased axonal integrity. The study was published in the February 2020 issue of Neurobiology of Disease.
“The circadian rhythm is one of the most powerful influences on human behavior. Daily exposure to blue wavelength light each morning helps to re-entrain the circadian rhythm so that people get better, more regular sleep. This is likely true for everybody, but we recently demonstrated it in people recovering from mTBI,” said lead author Professor William Killgore, MD. “That improvement in sleep was translated into improvements in cognitive function, reduced daytime sleepiness, and actual brain repair.”
Melatonin, discovered in 1958, is a hormone released by the pineal gland that regulates the sleep–wake cycle. It is involved in synchronization of the circadian rhythm, including sleep-wake timing and blood pressure regulation. For most animals, the timing of sleep and wakefulness is in synch with the circadian control of the sleep cycle and all other circadian-controlled rhythms. Humans, on the other hand, have the unique ability to cognitively override their internal biological clock and its rhythmic outputs.
Related Links:
University of Arizona
Researchers at the University of Arizona (Tucson, USA) conducted a randomized, double-blind, placebo-controlled trial of 32 adults (18–48 years of age) recovering from a recent mTBI. The researchers compared of cumulative six weeks of daily 30-minute pulses of blue light (469 nm) each morning to an amber (578 nm) placebo light on neurocognitive and neuroimaging outcomes, including gray matter volume (GMV), resting-state functional connectivity, directed connectivity using Granger causality, and white matter integrity using diffusion tensor imaging (DTI).
According to the researchers, blue light suppresses brain production of melatonin. Exposure to blue light in the morning shifts the brain's biological clock so that is produced earlier, aligning it with the natural circadian rhythm. The results showed that relative to placebo, morning blue light led to phase-advanced sleep timing, reduced daytime sleepiness, higher executive functioning, increased GMV of the posterior thalamus, greater thalamo-cortical functional connectivity, and increased axonal integrity. The study was published in the February 2020 issue of Neurobiology of Disease.
“The circadian rhythm is one of the most powerful influences on human behavior. Daily exposure to blue wavelength light each morning helps to re-entrain the circadian rhythm so that people get better, more regular sleep. This is likely true for everybody, but we recently demonstrated it in people recovering from mTBI,” said lead author Professor William Killgore, MD. “That improvement in sleep was translated into improvements in cognitive function, reduced daytime sleepiness, and actual brain repair.”
Melatonin, discovered in 1958, is a hormone released by the pineal gland that regulates the sleep–wake cycle. It is involved in synchronization of the circadian rhythm, including sleep-wake timing and blood pressure regulation. For most animals, the timing of sleep and wakefulness is in synch with the circadian control of the sleep cycle and all other circadian-controlled rhythms. Humans, on the other hand, have the unique ability to cognitively override their internal biological clock and its rhythmic outputs.
Related Links:
University of Arizona
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







